Icatibant Completed Phase 3 Trials for Hereditary Angioedema (HAE) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03888755A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants